NervGen Pharma Corp.
NGEN
$2.13
-$0.06-2.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 413.58% | -26.11% | 97.29% | -29.01% | 14.15% |
| Total Receivables | 109.67% | 3.23% | -75.98% | 138.98% | -60.77% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.38% | 608.88% | 78.32% | 72.19% | -0.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 59.90% | 250.97% | -63.41% | 27.26% | 52.71% |
| Total Current Assets | 332.02% | -12.02% | 83.04% | -24.84% | 12.91% |
|
|
|||||
| Total Current Assets | 332.02% | -12.02% | 83.04% | -24.84% | 12.91% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.46% | -4.89% | -1.78% | -5.21% | 2.14% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 325.60% | -11.90% | 80.30% | -24.34% | 12.61% |
|
|
|||||
| Total Accounts Payable | -30.90% | 50.50% | -28.32% | -2.79% | 7.09% |
| Total Accrued Expenses | -28.51% | 24.14% | -12.37% | 1.42% | 22.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -74.48% | -43.50% | -25.66% |
| Total Finance Division Other Current Liabilities | 619.57% | -38.92% | 44.68% | -17.54% | 34.20% |
| Total Other Current Liabilities | 619.57% | -38.92% | 44.68% | -17.54% | 34.20% |
| Total Current Liabilities | 369.31% | -24.03% | 25.14% | -12.09% | 30.13% |
|
|
|||||
| Total Current Liabilities | 369.31% | -24.03% | 25.14% | -12.09% | 30.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 369.31% | -24.03% | 25.14% | -12.09% | 30.13% |
|
|
|||||
| Common Stock & APIC | 36.11% | 3.15% | 15.64% | 0.20% | 13.07% |
| Retained Earnings | -17.28% | 0.40% | -24.40% | -1.86% | -14.43% |
| Treasury Stock & Other | -4.17% | -3.93% | 81.58% | 0.02% | 8.71% |
| Total Common Equity | 205.51% | 56.95% | 220.07% | -213.62% | -169.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 205.51% | 56.95% | 220.07% | -213.62% | -169.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 205.51% | 56.95% | 220.07% | -213.62% | -169.66% |
|
|
|||||